 |
Your Future in Pharmacy: Attend an Ownership Workshop
You need the right tools to run a stronger business and be a better owner to survive and thrive in today's highly competitive health care marketplace. This proven program is ideal both for those thinking about buying their first pharmacy or opening another. Register now for a 2012 Pharmacy Ownership Workshop, sponsored by McKesson and in part by Pharmacists Mutual. Find out what it takes to own and operate a successful pharmacy. The first workshop is scheduled for Feb. 24-26 in Dallas. Seating is limited to ensure a high degree of personalized learning and interaction. Click here to register. |
 |
Drugs and Treatment
FDA: Additional Concentration of Infant Liquid Acetaminophen Available
Modern Medicine (01/13/12)
In a safety announcement, FDA notified the public that an additional concentration of liquid acetaminophen marketed for "infants" (160 mg/5 mL) is now available at local stores. Until now, only more read more...
Return to Headlines
Oxycodone Prescriptions Rose Sharply in New York
New York Times (01/11/12) Kleinfield, N.R.
Oxycodone prescriptions climbed 82 percent in New York from 2007 to 2010, according to a new study issued by state attorney general Eric T. Schneiderman. The report found that nearly 22.5 million prescriptions for all read more...
Return to Headlines
Teva Pharmaceuticals Gives Details of New Hydrocodone Painkiller
Associated Press (01/12/12)
A second drug company has confirmed it plans to market a new form of the powerful and addictive painkiller hydrocodone. Teva Pharmaceuticals says its product, TD Hydrocodone, is in the final stages of read more...
Return to Headlines
UK Body Recommends Lilly, Amylin Diabetes Drug Bydureon
Dow Jones Newswires (01/12/12) Stovall, Sten
The U.K.'s healthcare cost-effectiveness body has confirmed initial guidance recommending Eli Lilly and Amylin Pharmaceuticals' Type 2 diabetes drug Bydureon for use in the U.K.'s publicly funded read more...
Return to Headlines
|
|
|
Industry News
Amylin Outlines Corporate Strategy to Maximize Global Value of Diabetes Franchise and Advance Key Pipeline Candidates
Amylin Pharmaceuticals Press Release (01/09/12)
In a presentation at the 30th Annual J.P. Morgan Healthcare Conference, Amylin President and CEO Daniel M. Bradbury highlighted steps the company is taking to prepare for the planned U.S. launch this read more...
Return to Headlines
AstraZeneca Expands R&D Partnership Efforts With New Integration Office
PMLiVE (01/12/2012)
AstraZeneca's Research and Development division has a new team that will seek partnerships with leading public and private organizations to identify and capitalize on future science and read more...
Return to Headlines
AstraZeneca and IMS Health Announce Real-World Evidence Collaboration in Europe
AstraZeneca Press Release (01/11/12)
AstraZeneca has announced that it has entered into a three-year collaboration agreement with IMS Health, a provider of information, services and technology for the healthcare sector, to advance the use of read more...
Return to Headlines
CVS Will Pay $5M to End Drug Price Investigation
Associated Press (01/12/12)
CVS Caremark will pay $5 million to resolve allegations that one of its subsidiaries understated the price of several drugs. The payment will be used to reimburse Medicare prescription drug beneficiaries who paid more than read more...
Return to Headlines
Merck Hepatitis C Drug May ‘Anchor’ Future Worldwide Regimen
Bloomberg (01/10/12) Langreth, Robert
Merck has set a goal to become the leading manufacturer of drugs for the treatment of hepatitis C, and expressed hope that its new drug, MK-5172, which is currently in the second stage of testing, will lay the read more...
Return to Headlines
Walgreens Spat Sends Millions to New Pharmacies
SF Gate (01/12/12) Colliver, Victoria; Pender, Kathleen
A dispute between Walgreens and Express Scripts has been continuing for over a year, and the recent collapse of negotiations has prompted the ending of business relations since the beginning of January. Millions of patients read more...
Return to Headlines
|
|
|
Healthcare Legislation & Regulation and Medicaid/Medicare
House Panel Announces User Fee Hearings
The Hill (01/12/12) Pecquet, Julian
House Republicans have announced a slew of hearings on health industry fees aimed at speeding up federal regulators' review of new medicines before they can go to market. The Energy and Commerce health subcommittee will read more...
Return to Headlines
Raising Medicare Age Would Save $148 Billion, CBO Says
National Journal (01/10/12) McCarthy, Meghan; O'Donnell, Katy
The Congressional Budget Office has recently completed calculations on savings that would be generated by changing the eligibility ages for Medicare and Social Security. Gradually increasing the read more...
Return to Headlines
Slower Growth in Health Spending
New York Times (NY) (01/11/12)
The most recent federal data indicated that health care spending climbed in 2009 and 2010 at the slowest rate in five decades, increasing at about the same pace as the economy's growth. The driving force behind the read more...
Return to Headlines
States Oppose Obama Healthcare Medicaid Law
Reuters (01/10/12) Vicini, James
The twenty-six states that have challenged the healthcare overhaul recently filed a Supreme Court brief alleging that the healthcare law is trying to force states to expand their Medicaid programs unconstitutionally. Congress told states to read more...
Return to Headlines
|
Abstract News © Copyright 2012 INFORMATION, INC.
 |
|
|
FEATURED SPONSOR:
|
|
